Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06576076 · ClinicalTrials.gov registry record · NA

Cannabis, Linked Emotions, and Adolescent Risk Study

A NA study of Depression and Suicidal Ideation, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06576076 is a NA study of Depression and Suicidal Ideation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06576076, a NA study of Depression and Suicidal Ideation, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to disentangle relationships between acute cannabis use and withdrawal on proximal depression and suicide risk and recovery in adolescents ages 12-18 years by incorporating time-varying patterns of substance use, mood, and SI. This project aims to guide the development of scalable, individualized, accessible, and affordable interventions aimed to reduce depression and suicide risk among adolescents.

Interventions

  • BEHAVIORAL Contingency management for cannabis abstinence

Study Locations (1)

Massachusetts

  • Massachusetts General Hopsital - Boston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-02-18
Est. Completion 2029-04-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06576076

The ClinicalTrials.gov registry entry for NCT06576076 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (75% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Contingency management for cannabis abstinence is the first listed.

NCT06576076 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06576076 about?

NCT06576076 is a clinical study titled "Cannabis, Linked Emotions, and Adolescent Risk Study". The goal of this study is to disentangle relationships between acute cannabis use and withdrawal on proximal depression and suicide risk and recovery in adolescents ages 12-18 years by incorporating time-varying patterns of substance use, mood, and SI. This project aims to guide the development of s...

What is the current status of trial NCT06576076?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-02-18. Estimated completion is 2029-04-30.

What conditions does trial NCT06576076 study?

This clinical trial studies the following conditions: Depression, Suicidal Ideation, Adolescent Behavior, Cannabis Use.

What interventions are being tested in trial NCT06576076?

The interventions under investigation include: Contingency management for cannabis abstinence (BEHAVIORAL).

Who is sponsoring clinical trial NCT06576076?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06576076 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.